記事ID ： 15202

ヒトインターフェロン測定ELISAキット

カテゴリから探す > 抗体アッセイ > ELISA／ELISpot アッセイ > ELISA・EIA キット

メーカー名：PBL Assay Science

ヒトサンプル中のインターフェロンおよびインターフェロン受容体を測定する各種ELISAキットを販売しています。

IFN Alpha ELISA,Human
IFN Beta ELISA,Human
IFN Gamma Receptor 1 ELISA,Human
IFN Lambda ELISA,Human
Interferon Multiplex ELISA,Human

« 製品使用文献はこちら

« インターフェロン測定キット一覧

ヒトインターフェロンαサブタイプの仕様比較表

+++ Very Good ++ Good + Moderate - Not at all		品番 41115	品番 41135	品番 41100	品番 41105	品番 41110
+++ Very Good ++ Good + Moderate - Not at all		検出感度
IFN α Subtype	Gene	All Subtype Serum	All Subtype TCM	TCM	Multi-Subtype TCM	Multi-Subtype Serum
Human IFN-αA	IFNA2	+++	+++	++	++	++
Human IFN-α2	IFNA2	+++	+++	++	++	++
Human IFN-αA/D		+++	+++	++	++	++
Human IFN-αB2	IFNA8	+++	+++	-	++	++
Human IFN-αC	IFNA10	+++	+++	+	++	++
Human IFN-αD	IFNA1	+++	+++	++	++	++
Human IFN-αF	IFNA21	+++	+++	-	-	-
Human IFN-αG	IFNA5	+++	+++	+	++	++
Human IFN-αH	IFNA14	+++	+++	-	++	++
Human IFN-αI	IFNA17	+++	+++	+	++	++
Human IFN-αJ1	IFNA7	+++	+++	+	++	++
Human IFN-αK	IFNA6	+++	+++	++	++	++
Human IFN-α1	IFNA1	+++	+++	++	++	++
Human IFN-α4a	IFNA4	+++	+++	+	+	+
Human IFN-α4b	IFNA4	+++	+++	++	++	++
Human IFN-αWA	IFNA16	+++	+++	+	++	++
Human IFN-β		-	-	-	-	-
Human IFN-γ		-	-	-	-	-
Human IFN-ω		-	-	-	-	-
Rhesus Monkey IFN-α2		+	+	+	+/-	+/-

IFN Alpha ELISA,Human

品番	品名	Quantitative determination of Hu-IFN alpha	サイズ	サンプル量	測定範囲	有効期限
41115-1	VeriKine-HS Interferon α All Subtype ELISA Kit	A, 2, A/D, B2, C, D, G, H, I, J1, K, 1, 4b and WA in serum, plasma and TCM	1x96	100µL	1.95-125 pg/ml	製造から12カ月
41135-1	VeriKine-HS Human Interferon Alpha All Subtype TCM ELISA Kit	A, 2, A/D, B2, C, D, G, H, I, J1, K, 1, 4b and WA in TCM	1x96		1.95-125 pg/ml	製造から12カ月
41100-1	VeriKine Human Interferon Alpha ELISA Kit	A, 2, A/D, D, K and 4b in cell culture and media	1x96		12.5-500 pg/ml, 156-5000 pg/ml	製造から21カ月
41100-2	VeriKine Human Interferon Alpha ELISA Kit	A, 2, A/D, D, K and 4b in cell culture and media	5x96		12.5-500 pg/ml, 156-5000 pg/ml	製造から21カ月
41105-1	VeriKine Human Interferon Alpha Multi-Subtype ELISA Kit	A, 2, A/D, B2, C, D, G, H, I, J1, K, 1, 4b and WA in cell culture and media	1x96		12.5-500 pg/ml, 156-5000 pg/ml	製造から21カ月
41105-2	VeriKine Human Interferon Alpha Multi-Subtype ELISA Kit		5x96		12.5-500 pg/ml, 156-5000 pg/ml	製造から21カ月
41110-1	VeriKine Human Interferon Alpha Multi-Subtype Serum ELISA Kit	A, 2, A/D, B2, C, D, G, H, I, J1, K, 1, 4b and WA in cell culture and media	1x96		12.5-1000 pg/ml	製造から21カ月
41110-2			5x96		12.5-1000 pg/ml	製造から21カ月

品番41110-1 を用いた個別技術情報「ヒトインターフェロンαELISAの血漿マトリックス研究」について

品名	メーカー	品番	包装	希望販売価格
VeriKine-HS Interferon α All Subtype ELISA Kit, Human	PBL	41115-1	1 PLATE	￥190,000
VeriKine-HS Interferon α All Subtype TCM ELISA Kit, Human	PBL	41135-1	1*96 WELL [100 μl]	￥147,000
VeriKine Interferon α ELISA Kit, Human	PBL	41100-1	1 PLATE [100 μl]	￥133,000
VeriKine Interferon α ELISA Kit, Human	PBL	41100-2	5 PLATE [100 μl]	お問い合わせ
VeriKine Interferon α Multi-Subtype ELISA Kit, Human	PBL	41105-1	1 PLATE [100 μl]	￥139,000
VeriKine Interferon α Multi-Subtype ELISA Kit, Human	PBL	41105-2	5 PLATE [100 μl]	お問い合わせ
VeriKine Interferon α Multi-Subtype Serum ELISA Kit, Human	PBL	41110-1	1 PLATE [100 μl]	￥139,000
VeriKine Interferon α Multi-Subtype Serum ELISA Kit, Human	PBL	41110-2	5 PLATE [100 μl]	お問い合わせ

IFN Beta ELISA,Human

品番	品名	Quantitative determination of Hu-IFN Beta	サイズ	サンプル量	測定範囲	有効期限
41410-1	VeriKine Human Interferon Beta ELISA Kit	cell culture and media	1x96	100µL	50-4000 pg/ml	製造から18カ月
41410-2	VeriKine Human Interferon Beta ELISA Kit	cell culture and media	5x96	100µL	50-4000 pg/ml	製造から18カ月
41415-1	VeriKine-HS Human Interferon Beta Serum ELISA Kit	cell culture media, serum and plasma	1x96	50µL	1.2-150 pg/ml	製造から12カ月
41435-1	VeriKine-HS Interferon Beta TCM ELISA Kit	tissue culture media (TCM)	1x96	50µL	2.34 - 150 pg/ml	製造から12カ月

品名	メーカー	品番	包装	希望販売価格
VeriKine Interferon β ELISA Kit, Human	PBL	41410-1	1 PLATE [100 μl]	￥139,000
VeriKine Interferon β ELISA Kit, Human	PBL	41410-2	5 PLATE [100 μl]	お問い合わせ
VeriKine-HS Interferon β Serum ELISA Kit, Human	PBL	41415-1	1*96 WELL [50 μl]	￥190,000
VeriKine-HS Interferon Beta TCM ELISA Kit, Human	PBL	41435-1	1*96 WELL [100 μl]	￥168,000

メーカーチラシ:

IFN Gamma Receptor 1 ELISA,Human

品番	品名	Quantitative determination of Hu-IFN Gamma Receptor 1 (IFNGR1)	サイズ	サンプル量	測定範囲	有効期限
41580-1	VeriKine Human Interferon Gamma Receptor 1 ELISA Kit	serum, plasma, tissue culture media and cell lysates	1x96	100µL	9.38-300 pg/ml, 　234.38-7500 pg/ml, 　37.5-1200 pg/ml	製造から12カ月

品名	メーカー	品番	包装	希望販売価格
VeriKine Interferon γ Receptor 1 ELISA Kit, Human	PBL	41580-1	1 PLATE [100 μl]	￥179,000

IFN Lambda ELISA,Human

品番	品名	Quantitative determination of Human	サイズ	サンプル量	測定範囲	有効期限
61830-1	DIY Human IFN Lambda 2/3 (IL-28A/B) ELISA	Interferon Lambda 2/3 (Interleukin-28A/B)	Materials for 15x96- well plates	n/a	125-8000 pg/ml	製造から36カ月
61840-1	DIY Human IFN Lambda 1/2/3 (IL-29/28A/28B) ELISA	Interferon Lambda 1/2/3 (Interleukin29/28A/28B)	Materials for 15x96- well plates	n/a	62.5-4000 pg/ml	製造から36カ月

品名	メーカー	品番	包装	希望販売価格
DIY IFN λ 2/3 (IL-28A/B) ELISA, Human	PBL	61830-1	15 PLATE [15 x 96-well plates]	PBL社 618301 1 を参照
DIY IFN λ 1/2/3 (IL-29/28A/28B) ELISA, Human	PBL	61840-1	15 PLATE [15 x 96-well plates]	PBL社 618401 1 を参照

Interferon Multiplex ELISA,Human

品番	品名	Quantitative determination of Human	サイズ	サンプル量	検出限界	有効期限
51500-1	VeriPlex Interferon 9-Plex ELISA Kit, Human	IFN-α、IFN-β、IFN-ω、IFN-γ、IFN-λ、IL-1α、IL-6、IP-10、TNF-α	1x96	50 µL	3pg/ml	製造から12カ月

品名	メーカー	品番	包装	希望販売価格
VeriPlex Interferon 9-Plex ELISA Kit, Human	PBL	51500-1	1*96 WELL	販売終了

製品使用文献(一部)

VeriKine Human IFN-Alpha ELISA (品番：41100)

Jiang, S., et al., (2023), "Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma", Neuro-Oncology Advances, vdad117, DOI: 10.1093/noajnl/vdad117 (link)
Zhang, Z., et al., (2021), "IRF7 and RNH1 are modifying factors of HIV-1 reservoirs: a genome-wide association analysis", BMC Medicine, 19:282, DOI:10.1186/s12916-021-02156-5. (link)
Sabree, SA., et al., (2021), "Direct and indirect immune effecrs of CMP-001, a virus-like particle containing a TLR-9 agnoist", Journal of ImmunoTherapy of Cancer, 9:e002484, DOI: 10.1136/jitc-2021-002484 (link)

VeriKine Human IFN-Alpha Molti-Subtype ELISA (品番：41110)

Chathuranga, et al., (2023), "Gadd45b is critical for regolation of type I interferon signaling by facilitating G3BP-mediated stress granole formation", Cell Reports, 42(11):113358, PMID: 37917584, DOI: 10.1016/j.celrep.2023.113358 (link)
Abbasifard, M. et al., (2023), "Evaluation of the interaction between tumor growth factor-b and interferon type I pathways in patients with COVID-19: factoriung on ages 1 to 90 years", BMC Infect. Dis., 23(1):248, PMID: 37072722, DOI: 10.1186/s12879-023-08225-9, (link)
Tojo, S. et al., (2020), "Structural analysis reveals TLR7 dynamics underlying antagonism", Nat Commun., 11(1):5204, PMID: 33060576, DOI: 10.1038/s41467-020-19025-z (link)
Ding, Siyuan, et al. (2018). STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection. Nature, 8 pgs. PMID: 29662124. (link)

VeriKine-HS Human IFN-Alpha All-Subtype ELISA (品番：41115)

Biava, M. et al., (2023), "In Vitro and In Vivo Crosstalk between Type I IFN and IL-8 Responses in SARS-CoV-2 Infection", Microorganisms, 11(11):2787, PMID: 38004798, DOI: 10.3390/microorganisms11112787 (link)
Grunhagel, B., et al., (2023), "Reduction of IFN-I Responses by Plasmacytoid Dendritic Cells in a Longitudinal Trans Men Cohort, iScience, DOI: 10.1016/j.isci.2023.108209 (link)
Nagaoka, K. et al., (2023), "Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants", Viruses, 15:1304, DOI: 10.3390/v15061304 (link)
Kim, S.T. et al., (2023). "Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis", Arthritis Res. Ther., PMID: 36765391, DOI: 10.1186/s13075-023-02997-w (link)
Rajamanickam, A. et al., (2022), "Restoration of dendritic cell homeostasis and Type I/Type III interferon levels in convalescent COVID-19 individuals, BMC Immunol., 23(1):51, PMID: 36289478, DOI: 10.1186/s12865-022-00526-z (link)

VeriKine-HS Human IFN-Alpha All-Subtype TCM ELISA (品番：41135)

Bolut, O. et al., (2024), "Alendronate Modolates Cytokine Responses in Healthy Young Individuals After BCG Vaccination", Immunol Lett., PMID: 38479480, DOi: 10.1016/j.imlet.2024.106851 (link)
Ide, M. et al., (2024), "Hepatitis B virus evades the immune system by suppressing the NF-kB signaling pathway with DENND2A", Microbiol Spectr., e0378523, PMID: 38240571, DOI: 10.1128/spectrum.03785-23 (link)
Salzmann, R.J.S. et al., (2024), "Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis", Hepatol Commun., 8(3):e0380, PIMD: 38358371, DOI: 10.1097/HC9.0000000000000380, (link)
Roring RJ. et al., (2024), "MMR vaccination induces trained immunity via functional and metabolic reprogramming of γδ T cells", J. Clin Invest. e170848, PMID: 38290093, DOI: 10.1172/JCI170848 (link)
Heider, A. et al., (2024), "Characteristics of two zoonotic swine influenza A(H1N1) viruses isolated in Germany from diseased patients", International Journal of Medical Microbiology, 314:151609, DOI: 10.1016/j.ijmm.2024.151609 (link)

VeriKine Human IFN-Beta ELISA (品番：41410)

Callom, D. et al., (2024), "Major-Group-B Enterovirus popolations deleted in the noncoding 5' region of genomic RNA modolate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis:, PLoS Pathog. 20(5):e1012125, PMID: 38696536, DOI: 10.1371/journal.ppat.1012125 (link)
Delaunay, T. et al., (2024), "Exogenous non-coding dsDNA-dependent trans-activation of phagocytes aygments anti-tumor immunity", Cell Rep Med., PMID: 38677283, DOI: 10.1016/j.xcrm.2024.101528 (link)
Boeszoermenyi, A. et al., (2023), "A conformation-locking inhibitor of SLC15A4 with RASL proteostatic anti-inflammatory activity", Nat Commun., 14(1):6626, PMID: 37863876, DOI: 10.1038/s41467-023-42070-3 (link)
Gonzalez Lopez Ledesma, MM, et al., (2023), "Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation", PNAS, 120(23):e2220005120, PMID: 37252973, DOI: 10.1073/pnas.2220005120 (link)
Haikerwal, A. et al., (2022), "Inhibition of Venezuelan Equine Encephalitis Virus Using Small Interfering RNAs", Viruses, 14(8):1628, PMID: 35893693, DOI: 10.3390/v14081628 (link)

VeriKine-HS Human IFN-Beta ELISA (品番：41415)

Yu, Y. et al., (2024), "Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy", Mol Oncol., PMID: 38506049, DOI: 10.1002/1878-0261.13619 (link)
Lei, X. et al., (2024), "CD4+T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors", Cell Mol Immunol., PMID: 38383773, DOI: 10.1038/s41423-024-01133-1 (link)
Smith, KER., et al., (2023), "A phase I oncolytic virus trial with vesicolar stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanomia: safety, efficacy, and T cell responses", Front Immunol., 14:1279387, DOI: 10.3389/fimmun.2023.1279387 (link)
ollah, T.R. et al., (2023), "Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection", Nat Commun. 14(1):5666, PMID: 37723181, DOI: 10.1038/s41467-023-41381-9 (link)
Nagaoka, N., et al., (2022), "Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection", Viruses, 14(7):1399, DOI: 10.3390/v14071399 (link)

VeriKine-HS Human IFN-Beta TCM ELISA (品番：41435)

Luganini, A., et al., (2023), "Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication", Antiviral Res., 105734, PMID: 37852322, DOI: 10.1016/j.antiviral.2023.105734 (link)
Barnard, T.R. et al., (2023), "Zika virus NS3 and NS5 proteins determine strain-dependent differences in dsRNA accumolation in a host cell type-dependent manner", J Gen Virol., 104(6):001855, PMID: 37289497, DOI: 10.1099/jgv.0.001855 (link)
Gori Savellini, G. et al., (2023), "SARS-COV-2 omicron sub-lineages differentially modolate interferon response in human lung epithelial cells", Virus Res., 332:199134, PMID: 37192725, DOI: 10.1016/j.virusres.2023.199134 (link)
Kwart, D. et al., (2022), "Cancer cell-derived type I interferons instruct tumor monocyte polarization", Cell Rep., 41(10):111769, PMID: 36476866, DOI:10.1016/j.celrep.2022.111769 (link)